Evidence map›Paper›PMID 36100130›Full record

ArticleJournal of vascular surgery. Venous and lymphatic disorders2023

Race affects adverse outcomes of deep vein thrombosis, pulmonary embolism, and acute kidney injury in coronavirus disease 2019 hospitalized patients.

Young Erben, Christopher P Marquez, Mercedes Prudencio, Susana Fortich, Tania Gendron, Devang Sanghavi, LaTonya Hickson, Yupeng Li, Michael A Edwards, Charles Ritchie and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of vascular surgery. Venous and lymphatic disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Young ErbenDivision of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL. Electronic address: erben.young@mayo.edu.
Christopher P MarquezDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL.
Mercedes PrudencioDepartment of Neuroscience and Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Jacksonville, FL.
Susana FortichDivision of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL.
Tania GendronDepartment of Neuroscience and Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Jacksonville, FL.
Devang SanghaviDepartment of Critical Care, Mayo Clinic, Jacksonville, FL.
LaTonya HicksonDivision of Nephrology and Hypertension, Mayo Clinic, Jacksonville, FL.
Yupeng LiDepartment of Political Science and Economics, Rowan University, Glassboro, NJ.
Michael A EdwardsDepartment of General Surgery, Mayo Clinic, Jacksonville, FL.
Charles RitchieDepartment of Radiology, Mayo Clinic, Jacksonville, FL.
Pablo Moreno FrancoDepartment of Critical Care, Mayo Clinic, Jacksonville, FL.
Leonard PetrucelliDepartment of Neuroscience and Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Jacksonville, FL.
James F MeschiaDepartment of Neurology, Mayo Clinic, Jacksonville, FL.
Mayo Clinic in Florida · USWinnMed · USRowan University · US

Funding

DISCOVERY - Statistics and Analysis CoreU19NS115388 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Steven M Greenberg, Natalia S Rost · 2019 to 2026
$75.4M
CREST-2 Clinical Coordinating CenterU01NS080168 · NINDS · MAYO CLINIC JACKSONVILLE · PI Thomas G Brott, JAMES F MESCHIA · 2014 to 2026
$56.3M
Project 3: Neuropathology of the multi-proteinopathy of c9FTD/ALS.P01NS084974 · NINDS · MAYO CLINIC JACKSONVILLE · PI PETRUCELLI, LEONARD · 2014 to 2024
$17.6M
Expanding insights into FTD disease mechanismsR35NS097273 · NINDS · MAYO CLINIC JACKSONVILLE · PI PETRUCELLI, LEONARD · 2017 to 2024
$10.6M
Validation of r(G4C2)exp-binding small molecules in vivo and c9FTD/ALS biomarker developmentP01NS099114 · NINDS · UNIVERSITY OF FLORIDA · PI DISNEY, MATTHEW D · 2017 to 2021
$6.5M
Stathmin-2 and TDP-43 neurodegeneration in Alzheimer’s and multi-etiology dementiasRF1NS120992 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Keith A Josephs, Mercedes Prudencio · 2021 to 2026
$4.2M
NINDS NIH HHS P01 NS084974NINDS NIH HHS P01 NS099114NINDS NIH HHS R35 NS097273NINDS NIH HHS RF1 NS120992NINDS NIH HHS U01 NS080168NINDS NIH HHS U19 NS115388
6 · The paper itself

Abstract

objectiveThe purpose of the present study was to explore the racial disparities in the incidence of deep vein thrombosis (DVT), pulmonary embolism (PE), and acute kidney injury (AKI) in hospitalized patients with coronavirus disease 2019 (COVID-19).

methodsA retrospective analysis was performed of prospectively collected data of consecutive COVID-19 patients hospitalized from March 11, 2020 to May 27, 2021. The primary outcome measures were the incidence of DVT/PE and mortality. The secondary outcome measures included differences in the length of hospitalization, need for intensive care unit care, readmission, and AKI. Multivariable regression models were used to assess for independent predictors of the primary and secondary outcome measures.

resultsThe present study included 876 hospitalized patients with COVID-19. The mean age was 64.4 ± 16.2 years, and 355 were women (40.5%). Of the 876 patients, 694 (79.2%) had identified as White, 111 (12.7%) as Black/African American, 48 (5.5%) as Asian, and 23 (2.6%) as other. The overall incidence of DVT/PE was 8.7%. The DVT/PE incidence rates differed across the race groups and was highest for Black/African American patients (n = 18; 16.2%), followed by Asian patients (n = 5; 10.4%), White patients (n = 52; 7.5%), and other (n = 1; 4.4%; P = .03). All but one of the hospitalization outcomes examined demonstrated no differences according to race, including the hospitalization stay (P = .33), need for intensive care unit care (P = .20), readmission rates (P = .52), and hospital all-cause mortality (P = .29). The AKI incidence differed among races, affecting a higher proportion of Black/African American patients (P=.003). On multivariable regression analysis, Black/African American race (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.0-4.0; P = .04) and higher D-dimer levels (OR, 1.1; 95% CI, 1.1-1.2; P < .0001) were predictors of DVT/PE. In addition, Black/African American race (OR, 2.3; 95% CI, 1.4-3.7; P = .001), lower hemoglobin levels (OR, 0.84; 95% CI, 0.8-0.9; P ≤ .0001), male sex (OR, 1.7; 95% CI, 1.2-2.4; P = .005), hypertension (OR, 2.1; 95% CI, 1.4-3.1; P = .0005), and older age (OR, 1.02; 95% CI, 1.006-1.03; P = .003) were predictors of AKI.

conclusionsIn our single-center case series, we found a higher incidence of DVT/PE and AKI among Black/African American patients with COVID-19. Black/African American race and D-dimer levels were independent predictors of DVT/PE, and Black/African American race, hemoglobin, and D-dimer levels were independent predictors of AKI.

Indexed as

Acute Kidney InjuryCOVID-19Pulmonary EmbolismVenous ThrombosisAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsCOVID-19Deep vein thrombosisPulmonary embolismRacial disparitiesVenous thromboembolism

Identifiers

PMID36100130
PMCPMC9463072
OpenAlexW4295760285

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.